NervGen Pharma Corp.
NGENF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $211,054 | $145,216 | $84,841 | $105,785 |
| - Cash | $17,267 | $11,660 | $22,452 | $16,929 |
| + Debt | $106 | $197 | $283 | $0 |
| Enterprise Value | $193,892 | $133,754 | $62,673 | $88,856 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$145 | -$115 | -$43 |
| % Margin | – | – | – | – |
| EBITDA | -$24,871 | -$17,722 | -$22,709 | -$12,769 |
| % Margin | – | – | – | – |
| Net Income | -$24,006 | -$22,382 | -$20,722 | -$12,727 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.36 | -0.38 | -0.39 | -0.32 |
| % Growth | 5.3% | 2.6% | -21.9% | – |
| Operating Cash Flow | -$16,841 | -$11,296 | -$17,784 | -$8,269 |
| Capital Expenditures | $0 | -$141 | -$21 | -$45 |
| Free Cash Flow | -$16,841 | -$11,437 | -$17,805 | -$8,314 |